Multi-center clincal study of administration glutamine on improvement prognosis in severe burn patients

The efficacy and safety of administration glutamine on reduction organ damage and improvement prognosis in severe burn patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001674

Enrollment

Unknown

Registered

2011-10-20

Start date

2010-02-23

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

burn

Interventions

A:glutamine

B:Routing treatment

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.18 – 65 years old, TBSA 30-80%; 2. No moderate to severe shock; 3. No moderate to severe inhalation injury; 4. No severe cardiovascular or digestive diseases before injury.

Exclusion criteria

Exclusion criteria: 1. Severe diseases in heart, liver, kidney or hematopoietic system before burn; 2. Severe asthma and chronic respiratory diseases before burn; 3. Severe heart and digestive diseases before burn; 4. Pregnant or lactating women; 5. Mental diseases, no self-control capacity or no articulate.

Design outcomes

Primary

Measure	Time frame
mortality;visceral complications;sepsis incidence;wound healing time;hospital stay;	—

Secondary

Measure	Time frame
myocardial zymogram;activity of DAO;cholinesterase;beta 2-microglobulin;	—

Countries

China

Contacts

Public ContactXi Peng

pxlrmm@163.com+86 13983402384

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026